|
|
|
| Guide to Good Clinical Practice, 3rd Edition |
|
| Table of Contents Published: 2007/09 |
| D&MD' s Guide to Good Clinical Practice, 3rd Edition updates the regulations and their respective amendments since the 2nd edition was published in 2005. The guide details the duties of the sponsors, institutional review boards (IRB), investigators, and t ... |
| Guide to Good Facility Design, 2nd Edition |
|
| Table of Contents Published: 2007/08 |
| Drug regulatory agencies require pharmaceutical and biopharmaceutical establishments to comply with Good Laboratory Practice (GLP) and Good Manufacturing Practice (GMP) regulations. D&MD' s Guide to Good Facility Design, 2nd Edition examines these regulat ... |
| Guide to Good Laboratory Practice, 3rd Edition |
|
| Table of Contents Published: 2007/08 |
| D&MD' s Guide to Good Laboratory Practice, 3rd Edition examines the GLP regulations in the United States and other countries in detail, and gives firm guidelines for compliance, using as a basis the GLP requirements published in the U.S.A Code of Federal ... |
| Guide to Good Validation Practice, 3rd Edition |
|
| Table of Contents Published: 2007/08 |
| D&MD' s Guide to Good Validation Practice, 3rd Edition is devoted to considering in greater detail the ways of complying with validation requirements at all stages of drug research, development and manufacture. The particular problems associated with the ... |
| Prescription Drug Counterfeiting |
|
| Table of Contents Published: 2007/04 |
| This report provides a unique examination and analysis of major global pharmaceutical markets, delivers a realistic description of counterfeiter capabilities, and covers new and emerging anti-counterfeiting technologies ... |
| Novel Targets in Drug Discovery |
|
| Table of Contents Published: 2006/11 |
| D&MD's Novel Targets in Drug Discovery report provides an overview of the concept of drug targets, and discusses their place in modern drug discovery. The report looks at the role of technologies such as genomics, proteomics and bioinformatics in target i ... |
| hERG: Technology and Market Analysis |
|
| Table of Contents Published: 2005/10 |
| D&MD' s hERG: Technology and Market Analysis Report is the only syndicated report that comprehensively addresses the hERG market landscape. The Report details the physiology and biology of hERG as well as its role in drug toxicity. ... |
| Rapid Viral Testing |
|
| Table of Contents Published: 2005/04 |
| Receive a thorough overview of the evolving field of rapid viral testing with D&MD's Rapid Viral Testing Report, including market forecasts through 2010. ... |
| Protein Arrays |
|
| Table of Contents Published: 2003/06 |
| This report will allow you to assess the market potential and opportunity gaps for high density arrays, primarily used for proteome wide analysis, verses low density arrays used principally for protein marker analysis. ... |
|
Top
|
|